Abstract:Background: Airway bacterial microbiota influences the prognosis in children with respiratory syncytial virus infection. The study aimed to investigate the effect of the airway-dominant bacterial microbiota on disease severity in children with pneumonia of respiratory syncytial virus infection. Methods: A retrospective study was conducted in the Children’s Hospital of Chongqing Medical University, which involved a cohort of patients with respiratory syncytial virus (RSV)-infected pneumonia from January 2012 to December 2021. Patients were assigned to a normal flora group or to a dominant flora group (with the top 5 individual bacteria) based on the nasopharyngeal aspirates culture and matched using propensity-score matching. Univariate analysis and multivariate analysis were performed to estimate the risk factors of poor prognosis in dominant flora. Results: Five thousand five hundred and twelve patients in the normal flora and 4556 in the dominant flora were included ( Escherichia coli 514, Streptococcus pneumoniae 1516, Staphylococcus aureus 506, Moraxella catarrhalis 509 and Haemophilus influenzae 1516, respectively). The dominant flora had more patients developing severe pneumonia, needing mechanical ventilation/tracheal intubation (up to 15.8% in the S. aureus ) and admission to the intensive care unit (up to 4.5% in the E. coli ) than in the normal flora (28.5% vs. 25.9%; P = 0.001; 9.8% vs. 5.4%; P < 0.001; 2.0% vs. 1.2%; P <0.001). And the hospitalization was longer in the dominant flora than in the normal flora [8 (6–9) vs. 8 (7–9) days; P < 0.001], the E. coli and S. aureus had the longest hospitalization [8 (7–10) days]. Several factors were associated with critical illness in Dominant flora according to multivariate analysis ( P < 0.001), including age (OR: 0.965; CI: 0.954–0.976; P < 0.001), anhelation (OR: 0.530; CI: 0.446–0.631; P < 0.001), disorders of consciousness (OR: 0.055; CI: 0.016–0.185; P < 0.001) as well as assisted respiration (OR: 0.115; CI: 0.097–0.138; P 10 mg/L (OR: 0.686; CI: 0.560–0.839; P < 0.001), SpO 2 <90% (OR: 0.366; CI: 0.214–0.628; P < 0.001), pulmonary consolidation (OR: 0.511; CI: 0.364–0.717; P < 0.001) and pulmonary atelectasis (OR: 0.362; CI: 0.236–0.555; P < 0.001). Conclusions: The airway-dominant bacterial microbiota influenced disease severity and comorbidities in children with RSV-infected pneumonia. Clinicians should pay attention to the nasopharyngeal aspirate culture, especially after detecting S. aureus and E. coli in RSV-infected children with pneumonia, closely observe the disease progression and take timely measures to avoid adverse outcomes.

Isolation of pathogenic bacteria from the nasopharynx of children with respiratory syncytial virus infection. Predictive value of chest roentgen examination and laboratory tests.

Epidemiological Characteristics and Immune Status of Children with Respiratory Syncytial Virus.

Reliable Detection of Respiratory Syncytial Virus Infection in Children for Adequate Hospital Infection Control Management

Blood culture and respiratory syncytial virus identification in acute lower respiratory tract infection

#11 Development of a Kinetic ELISA (kELISA) and Reactive B Cell Frequency (RBF) Assay to Detect Respiratory Syncytial Virus (RSV) Pre-Fusion F Protein-Specific Immune Responses in Infants

Bacteremia in Children Hospitalized Due to Respiratory Syncytial Virus Infection

Increased risk of bacterial pneumonia before and after respiratory syncytial virus infection in young children

Neutrophil Activation and Protease Imbalance in Respiratory Tract of Infants with Respiratory Syncytial Virus Bronchiolitis

Diagnosis of respiratory syncytial virus infection in children: Comparison of viral antigen detection and serology

RSV pneumonia with or without bacterial co-infection among healthy children

White blood cell count, C‐reactive protein and erythrocyte sedimentation rate in respiratory syncytial virus infection of the lower respiratory tract

Detection of respiratory syncytial virus in nasopharyngeal secretions by ELISA: Comparison with fluorescent antibody technique

Evaluation of viral respiratory pathogens in children aged under five hospitalized with lower respiratory tract infections

Biomarkers for Disease Severity in Children Infected With Respiratory Syncytial Virus: A Systematic Literature Review

Febrile infants without respiratory symptoms or sick contacts: are chest radiographs or RSV/influenza testing indicated?

The Prognosis in Children With Pneumonia of Respiratory Syncytial Virus Co-detection With Airway Dominant Flora

Burden of Respiratory Syncytial Virus Associated Severe Pneumonia in Hospitalized Children

Utility of Rapid Nasopharyngeal Swab for Respiratory Pathogens in the Diagnosis of Viral Infections in Children Hospitalized with Fever: A Prospective Validation Study to Improve Antibiotic Use

Comparison of nasopharyngeal aspirate and nasopharyngeal swab specimens for respiratory syncytial virus diagnosis by cell culture, indirect immunofluorescence assay, and enzyme-linked immunosorbent assay

Comparison of methods for laboratory diagnosis of respiratory syncytial virus